The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Drug Market Research Report 2025
Synopsis
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The global Veterinary Drug market was valued at US$ 23720 million in 2023 and is anticipated to reach US$ 34660 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.
This report aims to provide a comprehensive presentation of the global market for Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug.
Report Scope
The Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Pets
Cattle
Poultry
Swine
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The global Veterinary Drug market was valued at US$ 23720 million in 2023 and is anticipated to reach US$ 34660 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.
This report aims to provide a comprehensive presentation of the global market for Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug.
Report Scope
The Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Pets
Cattle
Poultry
Swine
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Veterinary Drug Market Overview
1.1 Product Overview and Scope of Veterinary Drug
1.2 Veterinary Drug Segment by Type
1.2.1 Global Veterinary Drug Market Value Comparison by Type (2024-2030)
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Veterinary Drug Segment by Application
1.3.1 Global Veterinary Drug Market Value by Application: (2024-2030)
1.3.2 Pets
1.3.3 Cattle
1.3.4 Poultry
1.3.5 Swine
1.3.6 Others
1.4 Global Veterinary Drug Market Size Estimates and Forecasts
1.4.1 Global Veterinary Drug Revenue 2019-2030
1.4.2 Global Veterinary Drug Sales 2019-2030
1.4.3 Global Veterinary Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary Drug Market Competition by Manufacturers
2.1 Global Veterinary Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Veterinary Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Veterinary Drug Average Price by Manufacturers (2019-2024)
2.4 Global Veterinary Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Drug, Product Type & Application
2.7 Veterinary Drug Market Competitive Situation and Trends
2.7.1 Veterinary Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Drug Players Market Share by Revenue
2.7.3 Global Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Drug Retrospective Market Scenario by Region
3.1 Global Veterinary Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary Drug Global Veterinary Drug Sales by Region: 2019-2030
3.2.1 Global Veterinary Drug Sales by Region: 2019-2024
3.2.2 Global Veterinary Drug Sales by Region: 2025-2030
3.3 Global Veterinary Drug Global Veterinary Drug Revenue by Region: 2019-2030
3.3.1 Global Veterinary Drug Revenue by Region: 2019-2024
3.3.2 Global Veterinary Drug Revenue by Region: 2025-2030
3.4 North America Veterinary Drug Market Facts & Figures by Country
3.4.1 North America Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary Drug Sales by Country (2019-2030)
3.4.3 North America Veterinary Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Drug Market Facts & Figures by Country
3.5.1 Europe Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary Drug Sales by Country (2019-2030)
3.5.3 Europe Veterinary Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Veterinary Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Drug Market Facts & Figures by Country
3.7.1 Latin America Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary Drug Sales by Country (2019-2030)
3.7.3 Latin America Veterinary Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Drug Sales by Type (2019-2030)
4.1.1 Global Veterinary Drug Sales by Type (2019-2024)
4.1.2 Global Veterinary Drug Sales by Type (2025-2030)
4.1.3 Global Veterinary Drug Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Drug Revenue by Type (2019-2030)
4.2.1 Global Veterinary Drug Revenue by Type (2019-2024)
4.2.2 Global Veterinary Drug Revenue by Type (2025-2030)
4.2.3 Global Veterinary Drug Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary Drug Sales by Application (2019-2030)
5.1.1 Global Veterinary Drug Sales by Application (2019-2024)
5.1.2 Global Veterinary Drug Sales by Application (2025-2030)
5.1.3 Global Veterinary Drug Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Drug Revenue by Application (2019-2030)
5.2.1 Global Veterinary Drug Revenue by Application (2019-2024)
5.2.2 Global Veterinary Drug Revenue by Application (2025-2030)
5.2.3 Global Veterinary Drug Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Veterinary Drug Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Corporation Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Elanco Veterinary Drug Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Veterinary Drug Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Virbac Veterinary Drug Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ceva Veterinary Drug Product Portfolio
6.6.5 Ceva Recent Developments/Updates
6.7 Vetoquinol
6.6.1 Vetoquinol Corporation Information
6.6.2 Vetoquinol Description and Business Overview
6.6.3 Vetoquinol Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vetoquinol Veterinary Drug Product Portfolio
6.7.5 Vetoquinol Recent Developments/Updates
6.8 Dechra
6.8.1 Dechra Corporation Information
6.8.2 Dechra Description and Business Overview
6.8.3 Dechra Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Dechra Veterinary Drug Product Portfolio
6.8.5 Dechra Recent Developments/Updates
6.9 Norbrook
6.9.1 Norbrook Corporation Information
6.9.2 Norbrook Description and Business Overview
6.9.3 Norbrook Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Norbrook Veterinary Drug Product Portfolio
6.9.5 Norbrook Recent Developments/Updates
6.10 Phibro
6.10.1 Phibro Corporation Information
6.10.2 Phibro Description and Business Overview
6.10.3 Phibro Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Phibro Veterinary Drug Product Portfolio
6.10.5 Phibro Recent Developments/Updates
6.11 Huvepharma
6.11.1 Huvepharma Corporation Information
6.11.2 Huvepharma Veterinary Drug Description and Business Overview
6.11.3 Huvepharma Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Huvepharma Veterinary Drug Product Portfolio
6.11.5 Huvepharma Recent Developments/Updates
6.12 Hipra
6.12.1 Hipra Corporation Information
6.12.2 Hipra Veterinary Drug Description and Business Overview
6.12.3 Hipra Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hipra Veterinary Drug Product Portfolio
6.12.5 Hipra Recent Developments/Updates
6.13 Ouro Fino Saude
6.13.1 Ouro Fino Saude Corporation Information
6.13.2 Ouro Fino Saude Veterinary Drug Description and Business Overview
6.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
6.13.5 Ouro Fino Saude Recent Developments/Updates
6.14 CAHIC
6.14.1 CAHIC Corporation Information
6.14.2 CAHIC Veterinary Drug Description and Business Overview
6.14.3 CAHIC Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 CAHIC Veterinary Drug Product Portfolio
6.14.5 CAHIC Recent Developments/Updates
6.15 Orion
6.15.1 Orion Corporation Information
6.15.2 Orion Veterinary Drug Description and Business Overview
6.15.3 Orion Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Orion Veterinary Drug Product Portfolio
6.15.5 Orion Recent Developments/Updates
6.16 Ringpu Biology
6.16.1 Ringpu Biology Corporation Information
6.16.2 Ringpu Biology Veterinary Drug Description and Business Overview
6.16.3 Ringpu Biology Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Ringpu Biology Veterinary Drug Product Portfolio
6.16.5 Ringpu Biology Recent Developments/Updates
6.17 Nippon Zenyaku Kogyo
6.17.1 Nippon Zenyaku Kogyo Corporation Information
6.17.2 Nippon Zenyaku Kogyo Veterinary Drug Description and Business Overview
6.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
6.17.5 Nippon Zenyaku Kogyo Recent Developments/Updates
6.18 Farmavet-Pasteur
6.18.1 Farmavet-Pasteur Corporation Information
6.18.2 Farmavet-Pasteur Veterinary Drug Description and Business Overview
6.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
6.18.5 Farmavet-Pasteur Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Drug Industry Chain Analysis
7.2 Veterinary Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Drug Production Mode & Process
7.4 Veterinary Drug Sales and Marketing
7.4.1 Veterinary Drug Sales Channels
7.4.2 Veterinary Drug Distributors
7.5 Veterinary Drug Customers
8 Veterinary Drug Market Dynamics
8.1 Veterinary Drug Industry Trends
8.2 Veterinary Drug Market Drivers
8.3 Veterinary Drug Market Challenges
8.4 Veterinary Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Veterinary Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Veterinary Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Veterinary Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Veterinary Drug Sales (M Units) of Key Manufacturers (2019-2024)
Table 5. Global Veterinary Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Veterinary Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Veterinary Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Veterinary Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Veterinary Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Veterinary Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Drug, Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Veterinary Drug Sales by Region (2019-2024) & (M Units)
Table 18. Global Veterinary Drug Sales Market Share by Region (2019-2024)
Table 19. Global Veterinary Drug Sales by Region (2025-2030) & (M Units)
Table 20. Global Veterinary Drug Sales Market Share by Region (2025-2030)
Table 21. Global Veterinary Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Veterinary Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Veterinary Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Veterinary Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Veterinary Drug Sales by Country (2019-2024) & (M Units)
Table 27. North America Veterinary Drug Sales by Country (2025-2030) & (M Units)
Table 28. North America Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Veterinary Drug Sales by Country (2019-2024) & (M Units)
Table 32. Europe Veterinary Drug Sales by Country (2025-2030) & (M Units)
Table 33. Europe Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Veterinary Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Veterinary Drug Sales by Region (2019-2024) & (M Units)
Table 37. Asia Pacific Veterinary Drug Sales by Region (2025-2030) & (M Units)
Table 38. Asia Pacific Veterinary Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Veterinary Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Veterinary Drug Sales by Country (2019-2024) & (M Units)
Table 42. Latin America Veterinary Drug Sales by Country (2025-2030) & (M Units)
Table 43. Latin America Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Veterinary Drug Sales by Country (2019-2024) & (M Units)
Table 47. Middle East & Africa Veterinary Drug Sales by Country (2025-2030) & (M Units)
Table 48. Middle East & Africa Veterinary Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Veterinary Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Veterinary Drug Sales (M Units) by Type (2019-2024)
Table 51. Global Veterinary Drug Sales (M Units) by Type (2025-2030)
Table 52. Global Veterinary Drug Sales Market Share by Type (2019-2024)
Table 53. Global Veterinary Drug Sales Market Share by Type (2025-2030)
Table 54. Global Veterinary Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Veterinary Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Veterinary Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Veterinary Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Veterinary Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Veterinary Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Veterinary Drug Sales (M Units) by Application (2019-2024)
Table 61. Global Veterinary Drug Sales (M Units) by Application (2025-2030)
Table 62. Global Veterinary Drug Sales Market Share by Application (2019-2024)
Table 63. Global Veterinary Drug Sales Market Share by Application (2025-2030)
Table 64. Global Veterinary Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Veterinary Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Veterinary Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Veterinary Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Veterinary Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Veterinary Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Zoetis Veterinary Drug Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Elanco Corporation Information
Table 76. Elanco Description and Business Overview
Table 77. Elanco Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Elanco Veterinary Drug Product
Table 79. Elanco Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Veterinary Drug Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Merck Veterinary Drug Product
Table 89. Merck Recent Developments/Updates
Table 90. Virbac Corporation Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Virbac Veterinary Drug Product
Table 94. Virbac Recent Developments/Updates
Table 95. Ceva Corporation Information
Table 96. Ceva Description and Business Overview
Table 97. Ceva Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Ceva Veterinary Drug Product
Table 99. Ceva Recent Developments/Updates
Table 100. Vetoquinol Corporation Information
Table 101. Vetoquinol Description and Business Overview
Table 102. Vetoquinol Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Vetoquinol Veterinary Drug Product
Table 104. Vetoquinol Recent Developments/Updates
Table 105. Dechra Corporation Information
Table 106. Dechra Description and Business Overview
Table 107. Dechra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Dechra Veterinary Drug Product
Table 109. Dechra Recent Developments/Updates
Table 110. Norbrook Corporation Information
Table 111. Norbrook Description and Business Overview
Table 112. Norbrook Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Norbrook Veterinary Drug Product
Table 114. Norbrook Recent Developments/Updates
Table 115. Phibro Corporation Information
Table 116. Phibro Description and Business Overview
Table 117. Phibro Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Phibro Veterinary Drug Product
Table 119. Phibro Recent Developments/Updates
Table 120. Huvepharma Corporation Information
Table 121. Huvepharma Description and Business Overview
Table 122. Huvepharma Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Huvepharma Veterinary Drug Product
Table 124. Huvepharma Recent Developments/Updates
Table 125. Hipra Corporation Information
Table 126. Hipra Description and Business Overview
Table 127. Hipra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Hipra Veterinary Drug Product
Table 129. Hipra Recent Developments/Updates
Table 130. Ouro Fino Saude Corporation Information
Table 131. Ouro Fino Saude Description and Business Overview
Table 132. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Ouro Fino Saude Veterinary Drug Product
Table 134. Ouro Fino Saude Recent Developments/Updates
Table 135. CAHIC Corporation Information
Table 136. CAHIC Description and Business Overview
Table 137. CAHIC Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. CAHIC Veterinary Drug Product
Table 139. CAHIC Recent Developments/Updates
Table 140. Orion Corporation Information
Table 141. Orion Description and Business Overview
Table 142. Orion Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Orion Veterinary Drug Product
Table 144. Orion Recent Developments/Updates
Table 145. Ringpu Biology Corporation Information
Table 146. Ringpu Biology Description and Business Overview
Table 147. Ringpu Biology Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Ringpu Biology Veterinary Drug Product
Table 149. Ringpu Biology Recent Developments/Updates
Table 150. Nippon Zenyaku Kogyo Corporation Information
Table 151. Nippon Zenyaku Kogyo Description and Business Overview
Table 152. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Nippon Zenyaku Kogyo Veterinary Drug Product
Table 154. Nippon Zenyaku Kogyo Recent Developments/Updates
Table 155. Farmavet-Pasteur Corporation Information
Table 156. Farmavet-Pasteur Description and Business Overview
Table 157. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. Farmavet-Pasteur Veterinary Drug Product
Table 159. Farmavet-Pasteur Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Veterinary Drug Distributors List
Table 163. Veterinary Drug Customers List
Table 164. Veterinary Drug Market Trends
Table 165. Veterinary Drug Market Drivers
Table 166. Veterinary Drug Market Challenges
Table 167. Veterinary Drug Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Drug
Figure 2. Global Veterinary Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Veterinary Drug Market Share by Type in 2023 & 2030
Figure 4. Anti-Infectives Product Picture
Figure 5. Anti-Inflammatory Product Picture
Figure 6. Parasiticides Product Picture
Figure 7. Analgesics Product Picture
Figure 8. Sedatives Product Picture
Figure 9. Others Product Picture
Figure 10. Global Veterinary Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Veterinary Drug Market Share by Application in 2023 & 2030
Figure 12. Pets
Figure 13. Cattle
Figure 14. Poultry
Figure 15. Swine
Figure 16. Others
Figure 17. Global Veterinary Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Veterinary Drug Market Size (2019-2030) & (US$ Million)
Figure 19. Global Veterinary Drug Sales (2019-2030) & (M Units)
Figure 20. Global Veterinary Drug Average Price (USD/Unit) & (2019-2030)
Figure 21. Veterinary Drug Report Years Considered
Figure 22. Veterinary Drug Sales Share by Manufacturers in 2023
Figure 23. Global Veterinary Drug Revenue Share by Manufacturers in 2023
Figure 24. The Global 5 and 10 Largest Veterinary Drug Players: Market Share by Revenue in 2023
Figure 25. Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 26. Global Veterinary Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 27. North America Veterinary Drug Sales Market Share by Country (2019-2030)
Figure 28. North America Veterinary Drug Revenue Market Share by Country (2019-2030)
Figure 29. U.S. Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Canada Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Europe Veterinary Drug Sales Market Share by Country (2019-2030)
Figure 32. Europe Veterinary Drug Revenue Market Share by Country (2019-2030)
Figure 33. Germany Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. France Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. U.K. Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Italy Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Russia Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Asia Pacific Veterinary Drug Sales Market Share by Region (2019-2030)
Figure 39. Asia Pacific Veterinary Drug Revenue Market Share by Region (2019-2030)
Figure 40. China Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Japan Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. South Korea Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. India Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Taiwan Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Indonesia Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Thailand Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Malaysia Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Philippines Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Latin America Veterinary Drug Sales Market Share by Country (2019-2030)
Figure 51. Latin America Veterinary Drug Revenue Market Share by Country (2019-2030)
Figure 52. Mexico Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Brazil Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Argentina Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Middle East & Africa Veterinary Drug Sales Market Share by Country (2019-2030)
Figure 56. Middle East & Africa Veterinary Drug Revenue Market Share by Country (2019-2030)
Figure 57. Turkey Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. UAE Veterinary Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. Global Sales Market Share of Veterinary Drug by Type (2019-2030)
Figure 61. Global Revenue Market Share of Veterinary Drug by Type (2019-2030)
Figure 62. Global Veterinary Drug Price (USD/Unit) by Type (2019-2030)
Figure 63. Global Sales Market Share of Veterinary Drug by Application (2019-2030)
Figure 64. Global Revenue Market Share of Veterinary Drug by Application (2019-2030)
Figure 65. Global Veterinary Drug Price (USD/Unit) by Application (2019-2030)
Figure 66. Veterinary Drug Value Chain
Figure 67. Veterinary Drug Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
